Skip to content

effect of Ashtadashanga Churna

Pharmaceutical and Efficacy study of Ashtadashanga churna in Pulmonary fibrosis related with post covid and Post tuberculosis.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047240
Enrollment
40
Registered
2022-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J708- Respiratory conditions due to other specified external agents

Interventions

None listed

Sponsors

Banaras Hindu University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients able to take medicines orally. 2. Patients willing to provide informed consent shall be included. 3. Subjects of Post covid-19 will considered upto12 months from the date of RTPCR negative.

Exclusion criteria

Exclusion criteria: 1. Lung fibrosis caused by any other means such as lung cancer, lymphangitis carcinomatosis, bronchiectasis, COPD (chronic obstructive pulmonary diseases),connective tissue disorder, rheumatoid arthritis. 2. Pulmonary oedema 3. Subjects with severe vomiting which would make oral administration of medicine difficult. 4. Pregnant and lactating subjects. 5. Subjects with severe disease conditions like malignancy and those with advance liver or kidney diseases. 6. Initially included subjects who during the treatment develops severe other infective diseases or trauma etc. 7. Active cases of TB and COVID.

Design outcomes

Primary

MeasureTime frame
Quality of life of post covid and post tuberculosis patients will be assessed on the basis of different criteria.Timepoint: 12 weeks

Secondary

MeasureTime frame
With the help of different parameters various changes took place after taking medicine will be assessed.Timepoint: 12 Weeks

Countries

India

Contacts

Public ContactSupriya Singh

Institute of Medical Science, Banaras Hindu University

krcreddy@bhu.ac.in9415813533

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026